XRAY (Dentsply Sirona) Research & Development: $158 Mil (TTM As of Mar. 2026)


XRAY Dentsply Sirona Inc XRAY
55 GF Score
Price $10.52
GF Value $19.06
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Dentsply Sirona Research & Development?

Dentsply Sirona XRAY +3.14% 55 Research & Development is $158 Mil as of Mar. 2026. GuruFocus rates XRAY with a GF Score™ of 55/100 and a GF Value™ of $19.06 (Possible Value Trap). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Dentsply Sirona's Research & Development for the three months ended in Mar. 2026 was $44 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $158 Mil.

Dentsply Sirona  (NAS:XRAY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Dentsply Sirona Research & Development Related Terms

Dentsply Sirona Research & Development Historical Data

* Premium members only.

The historical data trend for Dentsply Sirona's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dentsply Sirona Research & Development Chart

Dentsply Sirona Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 171.00 174.00 184.00 165.00 150.00

Dentsply Sirona Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.00 37.00 37.00 40.00 44.00
XRAY
55GF Score
Dentsply Sirona Inc XRAY
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dentsply Sirona Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $158 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $158 Mil mean?
Dentsply Sirona (XRAY) has a Research & Development of $158 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Dentsply Sirona and its competitors.
Is Dentsply Sirona's Research & Development too high?
Dentsply Sirona's current Research & Development is $158 Mil. Overall, Dentsply Sirona has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's Research & Development compare to LMAT and PLSE?
Dentsply Sirona's Research & Development of $158 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Dentsply Sirona and its competitors. Dentsply Sirona's current Research & Development is $158 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Possible Value Trap. The stock's GF Value™ is $19.06, compared to a current price of $10.52 — trading 44.8% below its estimated fair value. The current Research & Development is $158 Mil. Dentsply Sirona's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current Research & Development is $158 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dentsply Sirona (XRAY) Overvalued in 2026?

Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued. The current stock price of $10.52 is trading 44.8% below its estimated GF Value™ of $19.06. GuruFocus considers Dentsply Sirona to be Possible Value Trap.

Key valuation signals for XRAY:

  • Research & Development: $158 Mil
  • GF Value™: $19.06 vs. price of $10.52 (44.8% below fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dentsply Sirona Business Description

Address 13320 Ballantyne Corporate Place, Charlotte, NC, USA, 28277-3607
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
55GF Score

Get the complete analysis for XRAY

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.52
Price
$19.06
GF Value